Current role of albumin in critical care;Papel actual de la albúmina en cuidados críticos

Revista Espanola de Anestesiologia y Reanimacion

Volumn 61, Issue 9, 2014, Pages 497-504

  Aguirre Puig, P ^a   Orallo Moran M A ^a   Pereira Matalobos, D ^a   Prieto Requeijo, P ^a  

^a HOSPITAL XERAL CÍES   (Spain)

Author keywords

Albumin; Albumin and critical care; Albumin and sepsis; Colloid and critical care; Fluid therapy; Hypoalbuminemia and critical care

Indexed keywords

COLLOID; SERUM ALBUMIN;

ADVERSE EFFECTS; BLOOD; BRAIN INJURIES, TRAUMATIC; BURNS; CLINICAL TRIAL (TOPIC); COLLOID; CRITICAL ILLNESS; EVIDENCE BASED MEDICINE; FLUID THERAPY; HUMAN; HYPOALBUMINEMIA; INTENSIVE CARE; LIVER CIRRHOSIS; META ANALYSIS (TOPIC); MULTICENTER STUDY (TOPIC); OBSERVATIONAL STUDY; PHYSIOLOGY; PROCEDURES; RESPIRATORY DISTRESS SYNDROME, ADULT; SEPSIS;

BRAIN INJURIES, TRAUMATIC; BURNS; CLINICAL TRIALS AS TOPIC; COLLOIDS; CRITICAL CARE; CRITICAL ILLNESS; EVIDENCE-BASED MEDICINE; FLUID THERAPY; HUMANS; HYPOALBUMINEMIA; LIVER CIRRHOSIS; META-ANALYSIS AS TOPIC; MULTICENTER STUDIES AS TOPIC; OBSERVATIONAL STUDIES AS TOPIC; RESPIRATORY DISTRESS SYNDROME, ADULT; SEPSIS; SERUM ALBUMIN;

EID: 84908349309     PISSN: 00349356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redar.2014.04.016     Document Type: Short Survey

References (38)

1. Shafer S.L. Notice of retraction. Anesth Analg 2010, 111:1567.
2. Shafer S.L. Shadow of doubt. Anesth Analg 2011, 112:498-500.
3. Antonelli M., Maggiore S.M. Consensus statement of the ESICM task force on colloid volume therapy in critically ill patients. Intensive Care Med 2012, 38:1560.
4. Caironi P., Gattinoni L. The clinical use of albumin: The point of view of a specialist in intensive care. Blood Transfus 2009, 7:259-267.
5. Taverna M., Marie A.L., Mira J.P., Guidet B. Specific antioxidant properties of human serum albumin. Ann Intensive Care 2013, 3:4.
6. Friedman G., Jankowski S., Shahla M., Gomez J., Vincent J.L. Hemodynamic effects of 6% and 10% hydroxyethyl starch solutions versus 4% albumin solution in septic patients. J Clin Anesth 2008, 20:528-533.
7. Dubois M.J., Orellana-Jimenez C., Melot C., De Backer D., Berre J., Leeman M. Albumin administration improves organ function in critically ill hypoalbuminemic patients: A prospective, randomized, controlled, pilot study. Crit Care Med 2006, 34:2536-2540.
8. Perner A., Haase N., Wettersley J., Aneman A., Tenhunen J., Guttormsen A.B., et al. Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S--Scandinavian Starch for Severe Sepsis/Septic Shock trial): Study protocol, design and rationale for a double-blinded, randomised clinical trial. Trials 2011, 12:24. Scandinavian Critical Care Trials Group.
9. Dellinger R.P., Levy M.M., Rhodes A., Annane D., Gerlach H., Opal S.M., et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013, 39:165-228.
10. Annane D., Siami S., Jaber S., Martin C., Elatrous S., Declère A.D., et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: The CRISTAL randomized trial. JAMA 2013, 310:1809-1817.
11. Myburgh J.A., Finfer S., Bellomo R., Billot L., Cass A., Gattas D., et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012, 367:1901-1911.
12. Perner A., Haase N., Guttormsen A.B., Tenhunen J., Klemenzson G., Åneman A. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 2012, 367:124-134.
13. Human albumin administration in critically ill patients: Systematic review of randomised controlled trials. BMJ 1998, 317:235-240. Cochrane Injuries Group Albumin Reviewers.
14. Finfer S., McEvoy S., Bellomo R., McArthur C., Myburgh J., Norton R. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Med 2011, 37:86-96. SAFE Study Investigators.
15. Groeneveld A.B., Navickis R.J., Wilkes M.M. Update on the comparative safety of colloids: A systematic review of clinical studies. Ann Surg 2011, 253:470-483.
16. Vincent J.L., Sakr Y., Reinhart K., Sprung C.L., Gerlach H., Ranieri V.M. Is albumin administration in the acutely ill associated with increased mortality? Results of the SOAP study. Crit Care 2005, 9:745-754.
17. Maitland K., Kiguli S., Opoka R.O., Engoru C., Olupot-Olupot P., Akech S.O., et al. Mortality after fluid bolus in African children with severe infection. N Engl J Med 2011, 364:2483-2495.
18. Gattas D.J., Dan A., Myburgh J., Billot L., Lo S., Finfer S. Fluid resuscitation with 6% hydroxyethyl starch (130/0.4 and 130/0.42) in acute ill patients: Systematic review of effects on mortality and treatment with renal replacement therapy. Intensive Care Med 2013, 39:558-568. CHEST Management Committee.
19. Delaney A.P., Dan A., McCaffrey J., Finfer S. The role of albumin as a resuscitation fluid for patients with sepsis: A systematic review and meta-analysis. Crit Care Med 2011, 39:386-391.
20. Haase N., Perner A., Hennings L.I., Siegemund M., Lauridsen B., Wetterslev M., et al. Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: Systematic review with meta-analysis and trial sequential analysis. BMJ 2013, 346:f839.
21. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med 2007, 357:874-884. SAFE Study Investigators.
22. Bederson J.B., Connolly E.S., Batjer H.H., Dacey R.G., Dion J.E., Diringer M.N., et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 2009, 40:994-1025. American Heart Association.
23. Suarez J.L., Shannon L., Zaidat O.O., Suri M.F., Sing G., Lynch G., et al. Effect of human albumin administration on clinical outcome and hospital cost in patients with subarachnoid hemorrhage. J Neurosurg 2004, 100:585-590.
24. Suarez J.I., Martin R.H., Calvillo E., Dillon C., Bershad E.M., Macdonald R.L., et al. The Albumin in Subarachnoid Hemorrhage (ALISAH) multicenter pilot clinical trial: Safety and neurologic outcomes. Stroke 2012, 43:683-690.
25. Bhamidipati C.M., LaPar D.J., Mehta G.S., Kern J.A., Upchurch G.R., Kron I.L., et al. Albumin is a better predictor of outcomes than body mass index following coronary artery bypass grafting. Surgery 2011, 150:626-634.
26. Slattery E., Patchett S. Albumin as a marker of nutrition: A common pitfall. Ann Surg 2011, 254:667-668.
27. Russell J.A., Navickis R.J., Wilkes M.M. Albumin versus crystalloid for pump priming in cardiac surgery: Meta-analysis of controlled trials. J Cardiothorac Vasc Anesth 2004, 18:429-437.
28. Skhirtladze K., Base E.M., Lassnigg A., Kaider A., Linke S., Dworschak M., et al. Comparison of the effects of albumin 5%, hydroxyethyl starch 130/0.4 6%, and Ringer's lactate on blood loss and coagulation after cardiac surgery. Br J Anaesth 2014, 112:255-264.
29. Matthay M.A., Ware L.B., Zimmerman G.A. The acute respiratory distress syndrome. J Clin Invest 2012, 122:2731-2740.
30. Verheij J., van Lingen A., Raijmakers P.G., Rijnsburger E.R., Veerman D.P., Wisselink W., et al. Effect of fluid loading with saline or colloids on pulmonary permeability, edema and lung injury score after cardiac and major vascular surgery. Br J Anaesth 2006, 96:21-30.
31. Uhlig C., Silva P.L., Deckert S., Schmitt J., de Abreu M.G. Albumin versus crystalloid solutions in patients with the acute respiratory distress syndrome: A systematic review and meta-analysis. Crit Care 2014, 18:R10.
32. Pérez-Guisado J., de Haro-Padilla J.M., Rioja L.F., Derosier L.C., de la Torre J.I. Serum albumin levels in burn people are associated to the total body surface burned and the length of hospital stay but not to the initiation of the oral/enteral nutrition. Int J Burns Trauma 2013, 3:159-163.
33. Cooper A.B., Cohn S.M., Zhang H.S., Hanna K., Stewart T.E., Slutsky A.S., et al. Five percent albumin for adult burn shock resuscitation: Lack of effect on daily multiple organ dysfunction score. Transfusion 2006, 46:80-89.
34. Moreau R., Lebroc D. Acute renal failure in patients with cirrhosis: Perspectives in the age of MELD. Hepatology 2003, 37:233-243.
35. Umgelter A., Reindl W., Wagner K.S., Franzen M., Stock K., Schmid R.M., et al. Effects of plasma expansion with albumin and paracentesis on haemodynamics and kidney function in critically ill cirrhotic patients with tense ascites and hepatorenal syndrome: A prospective uncontrolled trial. Crit Care 2008, 12:R4.
36. Poca M., Concepción M., Casas M., Alvarez-Urturi C., Gordillo J., Hernández-Gea V., et al. Role of albumin treatment in patients with spontaneous bacterial peritonitis. Clin Gastroenterol Hepatol 2012, 10:309-315.
37. Salerno F., Navickis R.J., Wilkes M.M. Albumin infusion improves outcomes of patients with spontaneous bacterial peritonitis: A meta-analysis of randomized trials. Clin Gastroenterol Hepatol 2013, 11. 123.e1-130.e1.
38. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol 2010, 53:397-417. European Association for the Study of the Liver.